FDA reverses course and will review Moderna’s mRNA-based flu vaccine
Source: US news | The Guardian · Bias: Center Left
Summary
US drug regulator originally refused to consider application, fueling critics’ concern about alleged ‘anti-vaccine agenda’The Food and Drug Administration (FDA) reversed course on Wednesday and will now review Moderna’s application for the first mRNA-based flu vaccine after initially declining to consider it.Moderna announced that the US drug regulator will move forward with reviewing its updated flu vaccine application. The decision comes only a week after the agency turned down the company’s original filing, a move that had prompted criticism across the medical industry about potential changes in how the regulator is making decisions under the Trump administration. Continue reading...
Related Coverage
- Of course Mamdani takes opportunity to blast America in July 4 speech focused on ‘flaws’ (Right — New York Post)
- Restrictive Medication Abortion and HPV Vaccine Laws Take Effect in 3 States (Far Left — Truthout)
- Review: Gore Vidal's Burr Is the Anti-Hamilton (Center Right — Reason.com)
- MAGA Base Stays Quiet After Trump Reports Billions in Personal Gains (Center Left — NYT > U.S. > Politics)
- Castro says Air Force confirmed death from flu outbreak at Texas base (Center — The Hill News)
- Conservative National Review slams MAGA for 'abuse of' Amy Coney Barrett (Left — Alternet.org)
- Pentagon Official On Defense Base Rebuild (Center — Bloomberg Politics)
- DeGette loses reelection bid to DSA challenger in major upset for Denver-based House seat (Center — The Hill News)
More Headlines From February 18, 2026
- The canonization of Jesse Jackson (Center Right)
- Texas Election Season Heats Up as Early Voting in Senate Primaries Begins (Center Left)
- Telling clues revealed that US war imminent: '90% chance' (Far Left)
- Trump just gave the game away about his next military move (Far Left)
- Action demanded after new Epstein files point to 'crimes against humanity' (Left)








